Physician profile
Craig Dawkins
NPI 1124026034
$1,802.64
in general payments reported to CMS, 2019-2025
30 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $29.28 · 2021: $169 · 2022: $462 · 2023: $342 · 2024: $328 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $454.59 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $274.64 | 2021-2025 | Botox |
| Bayer Healthcare Pharmaceuticals INC. | $146.12 | 2020-2024 | |
| Pfizer INC. | $105.41 | 2022-2024 | |
| Boston Scientific Corporation | $77.97 | 2019-2024 | Lithovue |
| Sumitomo Pharma America, INC. | $62.90 | 2024-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $62.20 | 2022-2025 | |
| C. R. Bard, INC. & Subsidiaries | $58.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.89 | 2024-2025 | |
| Tolmar, INC. | $45.30 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $41.17 | 2023 | Pylarify |
| Allergan, INC. | $39.13 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $38.29 | 2019 | |
| Janssen Biotech, INC. | $35.04 | 2023-2024 | Erleada |
| Teleflex LLC | $27.82 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $24.40 | 2024 | Infyna Chic |
| Abc Home Medical Supply, INC. | $24.40 | 2024 | |
| Urogen Pharma, INC. | $24.29 | 2025 | |
| Myovant Sciences INC. | $21.74 | 2022 | |
| Endo Pharmaceuticals INC. | $21.03 | 2023 | Xiaflex, Aveed, Edex |
| Urovant Sciences INC | $20.29 | 2022 | |
| Coopersurgical, INC. | $20.00 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.92 | 2025 | Adstiladrin |
| Dendreon Pharmaceuticals LLC | $19.24 | 2024 | Provenge |
| Alnylam Pharmaceuticals INC. | $18.83 | 2023 | Givlaari |
| Astrazeneca Pharmaceuticals LP | $18.14 | 2025 | Farxiga |
| Exact Sciences Corporation | $15.94 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $15.83 | 2022 | |
| Profound Medical Corp. | $13.21 | 2022 | |
| Phathom Pharmaceuticals, INC. | $4.25 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Dawkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.